Related Experiment Video
Updated: May 18, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Role of colony-stimulating factors in atherosclerosis
Karina Di Gregoli1, Jason L Johnson
1Laboratory of Cardiovascular Pathology, School of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, UK.
Insights
Colony-stimulating factors (CSFs) create diverse macrophage populations influencing lipid processing and inflammation. Understanding CSF-driven macrophage heterogeneity is key to halting atherosclerosis progression and plaque rupture.
Area of Science:
- Cardiovascular Research
- Immunology
- Cell Biology
Background:
- Colony-stimulating factors (CSFs) influence monocyte and macrophage behavior.
- Macrophage heterogeneity plays a role in inflammation and atherosclerosis.
- Understanding CSF effects is crucial for managing cardiovascular disease.
Purpose of the Study:
- To investigate whether differing effects of CSFs dictate macrophage function and disease progression in atherosclerosis.
- To explore the role of CSFs in macrophage heterogeneity and its impact on atherogenesis.
Main Methods:
- Review of existing literature on CSFs, macrophages, and atherosclerosis.
- Analysis of molecular markers and genomic signatures associated with CSF-driven macrophage phenotypes.
- Examination of CSF levels as potential biomarkers for disease progression.
Main Results:
- CSFs generate heterogeneous monocyte-derived macrophages with distinct lipid processing and inflammatory capabilities.
- CSFs are present in atherosclerotic plaques and circulation, potentially serving as predictive biomarkers.
- Differential CSF exposure leads to divergent macrophage genomic signatures and functional properties, impacting atherogenesis.
Conclusions:
- Macrophage heterogeneity is critical in atherosclerosis development and progression.
- Identifying consistent markers for specific macrophage subsets is an active area of research.
- Further understanding of CSF regulation of macrophage phenotypes is needed for targeted therapeutic interventions against atherosclerosis.
Purpose Of Review:
The varied effects of colony-stimulating factors (CSFs) on monocytes and macrophages during inflammation and atherosclerosis and its clinical presentation prompt the question whether the differing effects of CSFs dictate macrophage function and disease progression.
Recent Findings:
CSFs can give rise to heterogeneous populations of monocyte-derived macrophages that are characterized by disparate expression of distinct molecules which dictate their ability to process lipid and regulate inflammatory and immune responses. The CSFs have been found within atherosclerotic plaques and in the circulation where their levels may act as predictive biomarkers of disease progression. Accordingly, differing exposure to these factors imparts divergent genomic signatures and functional properties on macrophages and may impact the multifactorial steps involved in atherogenesis, plaque progression and instability.
Summary:
Great interest in macrophage heterogeneity in the genesis and progression of atherosclerosis has led to the search for consistent markers of specific subsets in both animal models and humans. A better understanding of the overlap and competition between CSF regulation of macrophage phenotypes is therefore warranted, to allow their characterization in plaques. Subsequent targeted genetic and pharmacological intervention will facilitate the generation of therapeutic approaches to halt the progression and rupture of advanced atherosclerotic plaques.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Inflammation
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
